Cargando…
GC‐MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion
BACKGROUND: Tuberculous pleural effusions (TBPEs) and malignant pleural effusions (MPEs) are two of the most common and severe forms of exudative effusions. Clinical differentiation is challenging; however, metabolomics is a collection of powerful tools currently being used to screen for disease‐spe...
Autores principales: | Liu, Yongxia, Mei, Bin, Chen, Deying, Cai, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059743/ https://www.ncbi.nlm.nih.gov/pubmed/33528039 http://dx.doi.org/10.1002/jcla.23706 |
Ejemplares similares
-
High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion
por: Yi, Fengshuang, et al.
Publicado: (2019) -
Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion
por: Tang, Yimin, et al.
Publicado: (2019) -
Distinguishing tuberculosis pleural effusion from parasitic pleural effusion using pleural fluid characteristics: A case control study
por: Tong, Shuai, et al.
Publicado: (2019) -
Biomarkers for distinguishing tuberculous pleural effusion from non-tuberculosis effusion: a retrospective study
por: Fei, Guo, et al.
Publicado: (2023) -
Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion
por: Chen, Kuan-Yuan, et al.
Publicado: (2016)